April 12, 2021

FDA: Class I recall of Medtronic’s Valiant Navion Thoracic Stent Graft System

By: Judy Mathias
Share

Editor's Note

The Food & Drug Administration (FDA), on April 9, identified the recall of Medtronic’s Valiant Navion Thoracic Stent Graft System as Class I, the most serious.

The recall was initiated because of the risk of stent fractures and endoleak concerns. The system is used to repair lesions of the descending thoracic aorta.


Sponsored Message

There have been 11 reported issues, including two injuries and one death. Distribution dates were November 12, 2018 to February 10, 2021.

 

Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat